← Back to Search

Organ Preservation Device

OCS Liver System for Liver Transplant

N/A

Waitlist Available

Research Sponsored by TransMedics

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 and 12 months

Awards & highlights

Study Summary

This trial will test the OCS Liver System to see if it can effectively preserve and assess donor livers.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of EAD or primary non-function

Secondary outcome measures

OCS donor liver assessment during perfusion

Patient Survival at Day 30 post-transplantation

Patient Survival at initial hospital discharge post liver transplantation

Other outcome measures

Evidence of ischemic biliary complications diagnosed at 6 and 12 months post transplant

Extend to reperfusion syndrome as assessed based on the rate of decrease of lactate

Length of initial post-transplant ICU stay

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Treatment armExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

OCS Liver System

2020

N/A

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

TransMedicsLead Sponsor

22 Previous Clinical Trials

18,497 Total Patients Enrolled

Ahmed Elbetanony, MDStudy DirectorTransMedics

2 Previous Clinical Trials

309 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many locations are overseeing the progress of this experiment?

"This trial is being conducted at 16 different sites, which are geographically dispersed across the country. For those interested in participating, a clinic can be found close to you - Detroit, La Jolla and Memphis all have centres running this study. This will help reduce any necessary travel requirements during the duration of your involvement."

Answered by AI

Is this experiment accepting new participants?

"Unfortunately, this medical trial is no longer recruiting participants. First posted on February 3rd 2020 and last updated September 12th 2022, the study has successfully found all its needed patients. Nevertheless, there are currently 52 other clinical studies actively searching for volunteers."

Answered by AI

Recent research and studies

Current Opinion in Organ TransplantationJournal

Oncologic Indications of Liver Transplantation and Deceased Donor Liver Allocation in the United States

Kubal, Chandrashekhar, Plamen Mihaylov, and John Holden. 2021. “Oncologic Indications of Liver Transplantation and Deceased Donor Liver Allocation in the United States”. Current Opinion in Organ Transplantation. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/mot.0000000000000866.

Current Opinion in Organ TransplantationJournal

Oncologic Indications of Liver Transplantation and Deceased Donor Liver Allocation in the United States

clinicaltrials.govStudy

OCS Liver PROTECT Continued Access Protocol

2020. "OCS Liver PROTECT Continued Access Protocol". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04186221.